These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10861276)

  • 61. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy.
    Lin CY; Lin CC; Chang GJ; King CC
    Nephron; 1997; 76(2):176-85. PubMed ID: 9200409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran.
    Zhand S; Tabarraei A; Nazari A; Moradi A
    Indian J Gastroenterol; 2017 Jul; 36(4):253-257. PubMed ID: 28741237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genomic variations in precore and cytotoxic T lymphocyte regions in chronic hepatitis B in relationship to interferon responsiveness.
    Shindo M; Okuno T
    Liver; 2000 Apr; 20(2):136-42. PubMed ID: 10847482
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs.
    Zhou YH; Zhou J; Li L; Bi Y; Liu Y; Pan J; Wu C
    J Clin Virol; 2009 Dec; 46(4):363-6. PubMed ID: 19782639
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
    Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
    Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
    Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
    J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K; Arima K; Nishioka M
    J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Presence of hepatitis B surface antigen (HBsAg)-specific cytotoxic T cells in asymptomatic HBsAg carriers.
    Shu PY; Lin MY; Chang C; Hwang LH; Huang JH; Chang TH; Hu C
    J Infect Dis; 1994 Mar; 169(3):633-7. PubMed ID: 7512610
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B virus immunopathogenesis.
    Chisari FV; Ferrari C
    Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
    Depla E; Van der Aa A; Livingston BD; Crimi C; Allosery K; De Brabandere V; Krakover J; Murthy S; Huang M; Power S; Babé L; Dahlberg C; McKinney D; Sette A; Southwood S; Philip R; Newman MJ; Meheus L
    J Virol; 2008 Jan; 82(1):435-50. PubMed ID: 17942551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.